Spots Global Cancer Trial Database for Eniluracil Hand Foot Syndrome
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Eniluracil Hand Foot Syndrome
Official Title: A Pilot Study of Eniluracil Containing Ointment for Prevention of Hand Foot Syndrome (HRS) Following Capecitabine (Xeloda)
Study ID: NCT00827580
Interventions
Study Description
Brief Summary: A pilot study of eniluracil containing ointment for prevention of hand foot syndrome (HRS) following capecitabine (Xeloda).
Detailed Description: Primary Objectives 1. To estimate the frequency of HFS following treatment with capecitabine as modulated by the unilateral local application of eniluracil containing ointment. 2. To assess any eniluracil dose response relationship in prevention of HFS. 3. To evaluate any potential toxicity of eniluracil ointment.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Clinical Trials Research Unit, West Virginia University, Morgantown, West Virginia, United States
Contact Details
Name: William P. Petros, Pharm D
Affiliation: West Virginia University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
